Heartland Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,000
Closed -$6.07M 205
2021
Q4
$6.07M Hold
60,000
0.36% 129
2021
Q3
$5.53M Hold
60,000
0.33% 127
2021
Q2
$6.15M Buy
60,000
+10,000
+20% +$1M 0.36% 125
2021
Q1
$4.88M Buy
+50,000
New +$4.55M 0.31% 135
2015
Q1
Sell
-50,000
Closed -$2.56M 260
2014
Q4
$2.56M Sell
50,000
-72,874
-59% -$3.58M 0.05% 222
2014
Q3
$4.53M Buy
122,874
+42,874
+54% +$1.55M 0.09% 189
2014
Q2
$3.13M Buy
80,000
+30,000
+60% +$1.11M 0.05% 213
2014
Q1
$1.88M Buy
+50,000
New +$1.75M 0.03% 229

Other funds holding USNA

Heartland Advisors's USNA Position: Q1 2022 in Review

Heartland Advisors sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 60,000 shares — an estimated $6.07M sold.

Heartland Advisors first reported a position in USNA in Q1 2014 and held it in 8 quarters. The position peaked at $6.15M in Q2 2021. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.

  • Heartland Advisors reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
  • Heartland Advisors sold 60,000 Usana Health Sciences shares in Q1 2022, an estimated $6.07M.
  • Heartland Advisors first reported a position in Usana Health Sciences in Q1 2014 and held it in 8 quarters.
  • Heartland Advisors's Usana Health Sciences position peaked at $6.15M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.

Based on Heartland Advisors's 13F filing for Q1 2022, filed 12 May 2022.